54 results
8-K
EX-10.3
DMKPQ
DMK Pharmaceuticals Corp
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
on the date of grant, Participant will be solely responsible for Participant’s costs related to such a determination.
I-7
18. DATA PRIVACY. Optionee … different data privacy laws and protections than Optionee’s country.
19. REPRESENTATIONS OF HOLDER. The Holder represents and warrants to the Company
8-K
EX-10.4
DMKPQ
DMK Pharmaceuticals Corp
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
costs related to such a determination.
18. DATA PRIVACY. Optionee hereby explicitly and unambiguously consents to the collection, use and transfer … States), or elsewhere, and that the recipient’s country may have different data privacy laws and protections than Optionee’s country.
I-7
19
8-K
EX-10.1
DMKPQ
DMK Pharmaceuticals Corp
3 Aug 23
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
4:59pm
authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection
DEFM14A
kxlz37kz16wr1
13 Apr 23
Proxy related to merger
4:52pm
DEFA14A
EX-10.1
igbzrt69520mwfr
6 Jul 22
Additional proxy soliciting materials
6:04am
8-K
EX-10.1
jjdp1gv1bm69831
6 Jul 22
Entry into a Material Definitive Agreement
6:04am
8-K
EX-14.1
q9q58zkque6
18 Feb 22
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:43pm